Yorke Justin W. - 31 Dec 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role: Director
Signature: /s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol: PCSA
Transactions as of: 31 Dec 2022
Net transactions value: $0
Form type: 4
Filing time: 04 Jan 2023, 16:49:29 UTC
Previous filing: 04 Jan 2023
Next filing: 15 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCSA	Common Stock	Award		+18,208	+122%		33,093	31 Dec 2022	Direct	F1
holding	PCSA	Common Stock						532,563	31 Dec 2022	By Richland Fund, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCSA	Restricted Stock	Award	$0	+30,000		$0.000000	30,000	01 Jan 2023	Common Stock	30,000	$0.000000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Vesting of time-based restricted shares.
F2	The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.